Foundry Partners LLC bought a new stake in AngioDynamics, Inc. (NASDAQ:ANGO) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm bought 399,400 shares of the medical instruments supplier’s stock, valued at approximately $6,826,000. Foundry Partners LLC owned 1.09% of AngioDynamics as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in ANGO. UBS Asset Management Americas Inc. bought a new position in AngioDynamics in the 1st quarter valued at about $191,000. Parametric Portfolio Associates LLC boosted its stake in shares of AngioDynamics by 25.8% in the 1st quarter. Parametric Portfolio Associates LLC now owns 101,772 shares of the medical instruments supplier’s stock valued at $1,766,000 after purchasing an additional 20,901 shares in the last quarter. Municipal Employees Retirement System of Michigan boosted its stake in shares of AngioDynamics by 3.0% in the 1st quarter. Municipal Employees Retirement System of Michigan now owns 7,200 shares of the medical instruments supplier’s stock valued at $125,000 after purchasing an additional 210 shares in the last quarter. OppenheimerFunds Inc. boosted its stake in shares of AngioDynamics by 21.8% in the 1st quarter. OppenheimerFunds Inc. now owns 16,130 shares of the medical instruments supplier’s stock valued at $280,000 after purchasing an additional 2,883 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its stake in shares of AngioDynamics by 4.8% in the 1st quarter. Principal Financial Group Inc. now owns 253,474 shares of the medical instruments supplier’s stock valued at $4,398,000 after purchasing an additional 11,709 shares in the last quarter. 95.67% of the stock is currently owned by hedge funds and other institutional investors.
Shares of AngioDynamics, Inc. (NASDAQ ANGO) opened at $17.23 on Friday. AngioDynamics, Inc. has a one year low of $14.80 and a one year high of $18.85. The company has a quick ratio of 1.48, a current ratio of 2.34 and a debt-to-equity ratio of 0.17. The firm has a market cap of $632.62, a P/E ratio of 24.97, a PEG ratio of 1.77 and a beta of 1.05.
AngioDynamics (NASDAQ:ANGO) last posted its earnings results on Thursday, September 28th. The medical instruments supplier reported $0.12 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.04). AngioDynamics had a return on equity of 4.83% and a net margin of 1.64%. The business had revenue of $85.40 million for the quarter, compared to analyst estimates of $86.12 million. During the same quarter in the prior year, the business earned $0.17 earnings per share. The firm’s quarterly revenue was down 3.1% on a year-over-year basis. sell-side analysts anticipate that AngioDynamics, Inc. will post 0.65 earnings per share for the current year.
A number of research firms have recently weighed in on ANGO. BidaskClub downgraded shares of AngioDynamics from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. KeyCorp restated a “hold” rating on shares of AngioDynamics in a research note on Friday, September 29th. Zacks Investment Research upgraded shares of AngioDynamics from a “sell” rating to a “hold” rating in a research note on Monday, August 14th. Canaccord Genuity restated a “hold” rating and issued a $17.00 price target on shares of AngioDynamics in a research note on Sunday, October 8th. Finally, Barclays PLC reduced their price target on shares of AngioDynamics from $17.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 19th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $18.60.
AngioDynamics Company Profile
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).
What are top analysts saying about AngioDynamics Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for AngioDynamics Inc. and related companies.